Trial reportEuropean journal of sport science2026
Post-Exercise R-1,3-Butanediol did not Improve Markers of Fatigue or Recovery During a Multi-Stage Mountain Bike Race.
Trial report in European journal of sport science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence suggests that exogenous ketosis (EK) induced by ketone monoester (KME) supports recovery and attenuates physiological stress during endurance exercise. However, the potential benefits of the ketone precursor R-1,3-butanediol (BDO) during real-world multi-stage cycling remain unknown. We investigated the effects of post-exercise BDO supplementation on physiological strain, dietary intake, hydration, cognitive function, sleep, and subjective recovery during the 2025 Absa Cape Epic mountain bike race. In this double-blind, placebo-controlled study, 18 trained mountain bikers (10 teams) completed an 8-day multi-stage race. Participants received either 87.5 mL ketone IQ (BDO) or a placebo (CON) twice daily (post-stage and pre-sleep). Heart rate, energy intake, sleep metrics, cognitive performance, and subjective stress-recovery were monitored throughout the race. BDO induced mild post-stage ketosis (∼1.0 mM β-hydroxybutyrate) from stage 1 onwards. Across the race, both groups demonstrated lower exercise heart rate, increased resting heart rate, increased energy and carbohydrate intake, and slower reaction time by stage 6, indicating accumulating physiological strain. BDO did not alter any of these effects compared with placebo. These findings suggest that the modest ketosis achieved with BDO was not effective under real-world racing conditions, highlighting the importance of formulation-specific and ecologically valid evaluations of exogenous ketosis strategies in future studies.
Indexed as
Identifiers
42852530What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.